Feasibility Study Company Independent Feasibility Analysis

Veterinary Practice & Animal Hospital · Asset Class

Veterinary Practice & Animal Hospital Feasibility & Market Studies

Independent, lender-grade analysis for veterinary practices and animal hospitals financed through SBA 7(a) and 504, USDA rural, conventional practice-finance, and net-lease capital. A veterinary practice is a going concern, cash flow and equipment plus heavy professional goodwill, not passive real estate. This page is our standing read on where the market is feasible, how ramp-up and production forecasts fail review, and the difference between the market study, the feasibility study, and the going-concern appraisal a lender requires.

Request a methodology briefing Jump to the demand & labor monitor
$41B
2025 U.S. veterinary-care spending3
4.1%
Veterinary 7(a) charge-off vs 15.4% all-industry18
~50%
U.S. clinics corporate-owned, up from 8% in 201116
70–90%
Goodwill as a share of purchase price17
The Veterinary Thesis

The building is not the collateral. The practice is.

A veterinary practice is a going-concern professional-services healthcare business, valued on cash flow and business-enterprise value, real estate plus FF&E and medical equipment plus heavy professional goodwill, not as passive real estate. That single distinction separates it from the multifamily, retail, and net-lease assets underwritten as income property: here the doctor roster and the client base are the analysis, and goodwill alone commonly runs 70 to 90 percent of the purchase price.17 We prepare the market study, the feasibility study, and the going-concern appraisal input a veterinary file needs, aligned to the standard that will judge it.

The asset class earns its lender favor honestly. Veterinary services are recession-resistant, cash-flow-rich, and licensed, and they default rarely: veterinary-services SBA 7(a) loans charge off at roughly 4.1 percent on a resolved-loan basis versus about 15.4 percent across all industries, and Today's Veterinary Business cites a 7(a) loan-failure rate within the profession of just 0.92 percent on 2008 to 2017 originations.18 Demand is secular: APPA reports $41 billion of U.S. veterinary spending in 2025, up 3 percent and 25.9 percent of a $158 billion pet economy.3 Yet the same asset class is now consolidating aggressively, corporate and private-equity ownership rose from about 8 percent of U.S. clinics in 2011 to roughly 50 percent by 2025, and about 75 percent for specialty and emergency, which compresses independent margins and bids up the doctors every practice needs.16

The two variables that most often change the credit decision are not on the balance sheet. The DVM and credentialed-technician labor supply is the binding capacity constraint, and the departure of a selling owner-doctor can erode a client base built over decades. What follows is organized as a working desk: a demand, labor, and consolidation monitor, the ramp-up and production forensics that sink veterinary studies, the capital-source routing that decides which deliverable a project needs, and the study-type distinctions competitors state loosely. Every figure is dated and attributed in the sources below.

The Demand, Labor & Consolidation Monitor

Where veterinary feasibility stands, by market type.

Veterinary feasibility is driven by pet-owning-household density and income, DVM and technician labor availability, competition and corporate penetration, and facility cost, not raw population. Granular metro-level DVM supply and practice-density data are largely proprietary; state-level and market-type reads are the best available, and that data thinness is flagged in any trade-area study.

The national picture frames every market. The U.S. Census Bureau counted 34,296 veterinary practices in 2023, of which 82.6 percent are general medicine and surgery, 4.2 percent referral and specialty, and 3.4 percent production medicine, growing about 362 net new practices a year since 2010.1 Provider definitions diverge sharply, IBISWorld counts 56,756 veterinary-services businesses on a broader establishment basis and puts 2026 industry revenue at $74.5 billion, while Grand View Research sizes a services-only U.S. veterinarians market at $15.87 billion, figures that are not comparable across bases.24 Demand is durable in dollars, APPA reports veterinary care at $41 billion in 2025, up 3 percent, on a $158 billion pet economy, but softening in visits: Vetsource data show patient visits down 3.1 percent in 2025, the fourth straight down year after declines of 2.6 percent in 2024, 1.4 percent in 2023, and 3.5 percent in 2022, with the average interval between visits up from about 57.6 days in 2020 to 2021 to about 85.8 days in 2023 to 2024, a 48 percent increase.35 A PetSmart Charities-Gallup study found 52 percent of owners had skipped or declined care, 71 percent of them citing cost.7 The result is a class that is recession-resistant but no longer recession-proof at any price, and one where labor, not demand, is usually the binding constraint.

Opportunity read: Favorable Gated Thin / specialized. Bases differ by column and are not summed; the DVM-labor column is the key constraint variable, and a market can have strong demand yet be infeasible if a doctor cannot be recruited or retained.
Market type Pet-owning demand DVM / tech labor Competition / corporate Opportunity read
Secondary / tertiary citiesSolid, growing; Southeast and Midwest favoredNet-lease-buyer demandMore favorable than metrosIndependents still hold shareFavorableOften best risk-adjusted GP
High-income suburbanStrongest: high ownership, high per-pet spend, insured skewModerate; wage inflation as groups competeHigh; corporate-denseGatedDemand-strong, labor-gated
Rural / food-animal / mixedLower density; production demand; ~71% rural pet ownershipAcute shortage; 243 USDA shortage areas, 46 statesLow competition, thin client baseGatedUSDA support; per-DVM risk
Urban coreHigh density but high competition and rentTightest DVM competitionVery high; ~75% specialty/ER corporateSaturationER/specialty opportunity; GP risk
Equine belts (KY, FL, TX, CA)Niche, income-sensitiveVery few new grads (~1% equine)Low; specializedThin / specializedAmbulatory-heavy; distinct

Market-type reads compiled from AVMA 2025 Report on the Economic State of the Veterinary Profession, Vetsource, NAPHIA, PetDesk, and USDA Rural Development; see sources 1, 5, 10, 23, and 28. Metro-level DVM supply and practice-density series are largely proprietary (Vetsource, IBISWorld geographic chapters, VetWatch); this data thinness should be flagged in any trade-area study. Pet-insurance geography concentrates in California (18.3% of insured pets), New York, Florida, and Texas.

Spending is up, but visits have fallen four straight years

No figure on this page is more misread than demand. Pet-industry spending keeps climbing, APPA documents $152 billion in 2024 and $158 billion in 2025, with veterinary care up 3 percent to $41 billion and veterinary-services CPI running 7.6 to 7.9 percent a year in 2023 and 2024, well above general inflation.311 But the growth is in dollars per visit, not visits. Brakke Consulting reported 2025 revenue up about 2.5 percent even as visits fell about 3 percent, with 81 percent of veterinarians reporting clients more cost-sensitive than in 2024; within 2025 wellness visits fell 3.8 percent and product-only visits 6.2 percent as owners shifted to online pharmacies.65 Diagnostics and imaging are the highest-margin in-house lines and the growth vector, while pharmacy revenue erodes to online competition.22 Pet insurance is a growing but still-thin offset: NAPHIA reports $4.7 billion of U.S. gross written premium in 2024, up 21.4 percent, but only 3.9 percent market penetration.23 A pro forma resting on visit growth is therefore far riskier than the headline spending trend implies, and any study that models COVID-era visit gains as permanent, or ignores the 48 percent lengthening of inter-visit intervals, is not defensible.

The labor supply is the binding constraint, and it is genuinely contested

The workforce caps practice capacity and therefore value, and a defensible study presents both sides of the shortage debate. The shortage case: a Mars Veterinary Health study by Dr. Jim Lloyd (August 2023) projected a shortfall of 14,000 to 24,000 companion-animal veterinarians by 2030, an 11 to 18 percent gap against a need for 45,000 to 55,000, and AAVMC (2024) projects only about 76 percent of demand met by 2032.89 The no-shortage case: AVMA-commissioned Brakke analysis (2024) concludes existing colleges are adequate through at least 2035, with companion-animal numbers growing from about 80,000 in 2022 to 98,000-plus by 2030 as new schools open.6 All sources agree the market is extremely tight, veterinarian unemployment was 0.7 percent in the AVMA's 2024 Census against 3.9 percent for the U.S. workforce, that credentialed technicians are short and underpaid, NAVTA reports average technician gross income of $53,759 and "extremely satisfied" technicians down from 25 percent in 2022 to 8 percent in 2024,12 and that burnout is severe: a CDC study found female veterinarians up to 3.5 times more likely to die by suicide, and Merck estimates burnout costs the profession about $1.93 billion a year.101415 A 2010 JAVMA study tied each additional credentialed technician per veterinarian to about $93,311 in higher veterinarian gross income, the clearest evidence that the tech constraint directly caps practice revenue.13

Consolidation, the multiple gradient, and cap rates

Veterinary is one of the most aggressively consolidated healthcare verticals: corporate and PE ownership rose from about 8 percent of U.S. clinics in 2011 to roughly 50 percent by 2025, and about 75 percent for specialty and emergency.16 The anchor deals set the ceiling, Mars-VCA in 2017 at $9.1 billion and roughly 14 to 16 times EBITDA, and the Mission Pet Health platform at about $8.6 billion in December 2024, and the multiple gradient by size is the key transaction fact: solo owner-dependent practices cap near 3.5 to 6 times SDE, multi-doctor GP runs 7 to 11.5 times, and platform-scale assets reach 12 to 15 times EBITDA.19 Those peak multiples have since compressed roughly 1.5 to 2.5 turns amid higher rates, and the Ackerman Group notes corporate buyers pay 8 to 13 times today versus 5 to 6 times in 2016, even as invoice and visit growth has been negative three straight years, a compression signal that flags overpayment and goodwill-impairment risk.25 The separable clinic real estate trades on its own ruler: single-tenant net-leased veterinary real estate averaged about 6.9 percent, with Mars-credit assets tighter, Four Corners Property Trust closed a VCA hospital in New Jersey at a 7.1 percent cap in September 2025 and a BluePearl in Colorado at 7.0 percent, and franchisee or independent assets price wider above 7 percent.24

Common Review Failures

How veterinary feasibility and ramp-up forecasts fail review.

Ramp-up, staffing-to-capacity, and the acquisition multiple are the variables a credit committee scrutinizes most, and the places veterinary studies most often break. Each failure below is tied to a real mechanism or number.

  1. Revenue and production ramp assumed too fast

    De-novo clinics take years to fill a client base; one modeled scenario reached breakeven around month 25 with a Year-1 EBITDA loss near $230,000 before turning positive in Year 3. Underwriting that assumes mature production, roughly $1.5 million and a full active-client base, on day one is the classic error. Acquisitions inherit an existing base and are correspondingly lower-risk, a reason lenders favor them over startups.26

  2. DVM recruitment and retention risk

    The number-one issue. A practice cannot grow beyond the doctors it can staff. If the pro forma assumes a second or third associate DVM to hit revenue but the market cannot supply one, at 0.7 percent unemployment and an acute rural shortage, the ramp fails. Associate turnover, signing-bonus wage inflation, and corporate poaching are documented threats to the roster.10

  3. Goodwill and doctor-transition risk

    With goodwill at 70 to 90 percent of value, departure of the selling owner-DVM without an adequate transition period and enforceable non-compete can erode the client base and impair the collateral. Corporate buyers now routinely require 20 to 40 percent rollover equity and two-to-five-year employment agreements to bond the selling doctor; a study that capitalizes goodwill without these protections overstates recoverable value.17

  4. Production-per-DVM and capacity mis-estimation

    Overestimating revenue per DVM, national gross revenue per FTE veterinarian was $554,982 in 2024, far less in rural and mixed practice, or the number of doctors the exam rooms can support inflates projections. Companion-animal practice supports only about 13 to 14 appointment slots a day, roughly 6 in equine, and the rule of thumb is about 1,000 square feet and 2 to 2.5 exam rooms per veterinarian.21

  5. Acquisition-multiple, overpayment, and compression risk

    Paying peak 2020 to 2022 multiples into a market that has compressed 1.5 to 2.5 turns and seen four straight down-visit years creates goodwill-impairment and negative-equity risk. A solo practice priced above roughly 6 times SDE, or a multi-doctor GP above 9 to 10 times without platform characteristics, is a red flag, and corporate over-leverage, such as one large consolidator downgraded to CCC+, is a cautionary comp.2520

  6. Pet-spending and demand-normalization risk

    Modeling COVID-era visit growth as permanent while ignoring the 48 percent lengthening of inter-visit intervals and the 52 percent of owners skipping or declining care. Over-reliance on discretionary or product revenue is especially fragile, product-only visits fell 6.2 percent in 2025 as clients shifted to online pharmacies, and fee increases show diminishing returns as price sensitivity rises.57

  7. Equipment and imaging capital under-budgeted

    Diagnostic, surgical, and imaging equipment is commonly 30 to 50 percent of startup cost, and specialty MRI and CT run $800,000 to $1 million-plus. De-novo construction runs $225 to $400 per square foot with leasehold improvements around $130 to $200; a study that under-budgets the medical fit-out understates project cost and the reserve the ramp requires.26

  8. DSCR sizing, working capital, and operator experience

    Under-reserved working capital for a six-plus-month ramp, DSCR below program thresholds on stressed visit-down revenue, and an inexperienced owner-DVM without practice-management capability, owner time runs roughly 74 percent clinical and 22 percent management, all break the file. Size to DSCR at or above 1.25 times on stressed revenue and confirm licensure and DEA registration.21

Capital-Source Routing

Which channel funds the project, and what it requires.

Veterinary practices route through distinct capital sources, and each requires a different deliverable and coverage standard. The study is built to the union of requirements across the channels actually in play, and the first question is always whether the deal is an acquisition, a de-novo startup, or the real estate on its own.

The veterinary lender matrix
Deliverable and coverage convention by capital source. Coverage figures are market conventions, not universal minimums.27
Capital sourceDeliverableCoverage convention
SBA 7(a) (acquisition, goodwill, working capital)Going-concern business valuation + feasibilityUp to $5M; cash-flow-based; DSCR ~1.25x
SBA 504 (owner-occupied real estate)Going-concern appraisal, real estate / FF&E / goodwill split50% bank / 40% CDC / 10% borrower; 51% or 60% occupancy
Conventional / practice-finance lendersPractice valuation + production metricsUp to 100% for qualified DVMs; cash-flow-based
USDA B&I + VMLRP / VSGP (rural)Rural business feasibility80% / 70% / 60% guarantee by size; VMLRP up to $120K / 3 yrs
MOB / net-lease (the real estate)Income-approach appraisal on the leaseCap-rate-based; 1031 and net-lease buyers

Sources: SBA SOP 50 10 8; USDA Rural Development B&I, VMLRP, and VSGP term sheets; practice-finance lender guidelines. See sources 27 and 28.

Veterinary is one of the most favored SBA and professional-practice lending categories, and for good reason: recession-resistant recurring demand, cash-flow-based repayment, professional licensure, and very low default fit SBA underwriting almost perfectly. 7(a), up to $5 million, is the dominant tool for practice acquisition, goodwill, equipment, build-out, and working capital, precisely because it is cash-flow-based and can finance heavy goodwill without hard-asset collateral; a going-concern business valuation is standard for a change of ownership. 504 finances owner-occupied clinic real estate under the 50/40/10 structure and the 51 percent existing or 60 percent new-construction owner-occupancy test, and separating the real estate onto 504 or a net-lease structure from the goodwill-heavy going concern is often the optimal structure.27 One eligibility note worth stating plainly: green-card holders are no longer SBA-eligible under a 2025 rule change. For rural and food-animal practices, a genuine, federally recognized market failure, USDA Business & Industry guarantees pair with the Veterinary Medicine Loan Repayment Program and the Veterinary Services Grant Program to route capital and doctors into 243 designated shortage areas across 46 states.28

  • Practice acquisition with an inherited client baseSBA 7(a) with a going-concern business valuation; lower-risk than de-novo and the most common structure.
  • De-novo or startup clinicSBA 7(a) underwritten to a 24-to-36-month ramp with 6-to-12 months of working-capital reserve, or declined.
  • Owner-occupied clinic real estateSBA 504 under the 51% / 60% occupancy test, separated from the going concern where beneficial.
  • Rural, food-animal, or mixed practiceUSDA B&I plus VMLRP or VSGP support for the recruited DVM.
  • The clinic real estate as a separable assetConventional, CMBS, or net-lease financing on the income approach; cross-reference the medical-office monitor.
Study Types

Market study, feasibility study, appraisal: three questions.

These three documents answer different questions and are not substitutes. Lenders and borrowers conflate them constantly; SBA underwriters and credit committees do not.

What each document answers, and the standard that governs it.
DocumentQuestion answeredGoverning standard
AppraisalWhat is it worth? A going-concern / business-enterprise value, real estate plus FF&E and equipment plus goodwill, on an EBITDA or SDE multiple.USPAP + going-concern / BEV
Market studyIs there demand, and can it be staffed? Pet-owning-household demand, income, competition, and DVM labor availability in the trade area.Trade-area demand analysis
Feasibility studyDoes it pencil for this lender? The market study plus the production ramp, staffing-to-capacity, revenue mix, and DSCR.Lender underwriting + going-concern

The distinction that governs a veterinary file is that the practice is valued as a going concern, not as passive real estate. The income approach applies an EBITDA or SDE multiple to normalized earnings, with the multiple rising by size, small practices are SDE-based at lower multiples of roughly 3.5 to 6 times, larger multi-doctor practices EBITDA-based at 7 to 15 times given corporate-buyer demand, and the allocation among real property, equipment and FF&E, and goodwill is central for SBA goodwill financing and for tax purposes. Where the clinic real estate is owned or leased separately, it is valued as medical-office or net-lease real estate on a cap rate, a separable, financeable asset distinct from the goodwill-heavy going concern. The Ackerman Group frames the real-estate-versus-practice tradeoff directly: every dollar of higher rent to the buyer reduces practice EBITDA, so the owner must optimize whether the practice trades at a higher multiple than the real estate does.

One scope boundary is worth stating. Veterinary is relatively low environmental risk, but a lender will typically require a standard Phase I Environmental Site Assessment, and the feasibility or market-study author does not perform the Phase I or II ESA; that is a separate environmental professional's engagement. The market and feasibility work classifies the sub-type and ownership layer, values the going concern with an explicit goodwill allocation, and stress-tests the four decisive gates, DVM recruitment and retention, doctor-transition goodwill, production-per-DVM capacity, and the acquisition multiple; it does not opine on environmental condition, controlled-substance-waste, or radiology compliance.

Veterinary sub-segments, each with a distinct study scope

Veterinary Questions

Veterinary feasibility and market-study questions.

What is the difference between a veterinary market study and a feasibility study?

They answer different questions and are not substitutes, though the analytical work overlaps. A market study assesses pet-owning-household demand, income, competition, and, most decisively, DVM and technician labor availability in the trade area, and answers whether there is demand and whether the practice can be staffed. A feasibility study adds the specific practice's pro forma: the production and revenue ramp, staffing-to-capacity, revenue mix, the acquisition multiple, and debt-service coverage, and answers whether the deal pencils for this lender. Because a veterinary practice is a going concern rather than passive real estate, both are built around cash flow and the DVM roster, not the building.

How is a veterinary practice valued, as a business or as real estate?

As a going concern. Unlike passive multi-tenant real estate, a veterinary practice is valued as a business-enterprise value combining the real estate, the FF&E and medical and imaging equipment, and, the largest piece, professional goodwill, which commonly runs 70 to 90 percent of the purchase price. The income approach applies an EBITDA or SDE multiple to normalized earnings, and the multiple rises with size: solo owner-dependent practices are SDE-based at roughly 3.5 to 6x, while multi-doctor practices are EBITDA-based at 7 to 15x given corporate-buyer demand. Where the clinic real estate is owned or leased separately, it is valued as medical-office or net-lease real estate on a cap rate.

Why is veterinary a favored SBA lending category?

Veterinary practices fit SBA underwriting almost perfectly: recession-resistant recurring demand, cash-flow-based repayment, professional licensure, and very low default. On a resolved-loan basis, veterinary-services 7(a) loans charge off at roughly 4.1 percent versus about 15.4 percent across all industries per PeerSense (May 2026), and Today's Veterinary Business cites a 7(a) loan-failure rate within the industry of just 0.92 percent on 2008 to 2017 originations. Because the collateral is the business and its goodwill rather than hard assets, 7(a), which is cash-flow-based, is the dominant tool for practice acquisition, goodwill, equipment, build-out, and working capital.

Can a veterinary practice be financed with an SBA loan?

Yes, and it is one of the most common uses of SBA credit in professional services. SBA 7(a), up to $5 million, finances practice acquisition, goodwill, equipment, build-out, and working capital on a cash-flow basis, which is what allows it to finance high goodwill without hard-asset collateral; a going-concern business valuation is required for a change of ownership given that goodwill can be 70 to 90 percent of value. SBA 504 finances owner-occupied clinic real estate under the 50/40/10 structure and the 51 percent (existing) or 60 percent (new-construction) owner-occupancy test. De-novo startups are eligible but higher-risk and are underwritten to a multi-year ramp. Note that green-card holders are no longer SBA-eligible under a 2025 rule change.

Is there really a veterinarian shortage?

It is genuinely contested among named sources, and a defensible study presents both sides. The shortage case: a Mars Veterinary Health study by Dr. Jim Lloyd (August 2023) projected a shortage of 14,000 to 24,000 companion-animal veterinarians by 2030, and AAVMC (2024) projects only about 76 percent of demand met by 2032. The no-shortage case: AVMA-commissioned Brakke Consulting analysis (2024) concludes existing colleges are adequate through at least 2035. What all sources agree on is that credentialed technicians are short, burnout is severe, and the labor market is extremely tight, with veterinarian unemployment at 0.7 percent in the AVMA's 2024 Census against 3.9 percent for the U.S. workforce. The reconciling view is that shortages are regional and acute in rural, food-animal, and specialty and emergency settings.

Is pet-care demand recession-proof?

It is recession-resistant but no longer recession-proof at any price. Pet-care spending keeps rising, with APPA reporting $41 billion of U.S. veterinary spending in 2025, up 3 percent, but visit volume is falling: Vetsource data show patient visits down 3.1 percent in 2025, the fourth straight down year, with the average interval between visits up 48 percent since 2020 to 2021. A PetSmart Charities-Gallup study found 52 percent of owners had skipped or declined care, 71 percent of them citing cost. The lesson for underwriting is that a pro forma resting on visit growth is far riskier than the headline spending trend implies; volume-dependent projections must be stress-tested against discretionary deferral.

What is doctor-transition risk, and why does it matter to lenders?

Because goodwill can be 70 to 90 percent of a veterinary practice's value, and that goodwill lives in the client base, reputation, and relationships of the selling owner-veterinarian, the departure of that doctor without an adequate transition period and enforceable non-compete can erode the client base and impair the collateral almost immediately. This key-DVM dependence is the central intangible risk in the asset class. Lenders and corporate buyers manage it by requiring a documented transition, typically one to three years, a non-compete, and, for corporate deals, 20 to 40 percent rollover equity and multi-year employment agreements to bond the selling doctor. A study that capitalizes goodwill without confirming these protections overstates recoverable value.

By Market

Veterinary feasibility studies by state.

Pet-owning demand, DVM and technician labor availability, and the competitive and corporate-consolidation landscape are local. Explore the state markets where the client base, the doctor supply, and the regulatory layer determine whether a practice pencils.

Underwriting a veterinary acquisition or de-novo? Start with the going concern.

A methodology briefing walks through the analytical framework, the deliverable your capital source requires, and the current demand, labor, and multiple data for your sub-type and trade area.

Request a methodology briefing
Sources

Data sources and dates.

Every figure on this page traces to a named authority. Veterinary readings are point-in-time and basis-dependent; figures are labeled GP versus specialty, independent versus corporate, per-practice versus per-DVM, and going-concern versus real-estate-only, and are not compared across incompatible bases.

  1. U.S. Census Bureau (2023), cited in the AVMA 2025 Report on the Economic State of the Veterinary Profession: 34,296 veterinary practices; service mix 82.6% general medicine/surgery, 4.2% referral/specialty, 3.4% production medicine (2024 data); ~362 net new practices per year since 2010 (~1.3% annual growth); 93.9% of practices independently owned by count (2024 Veterinary Practice Owners Survey).
  2. IBISWorld, U.S. Veterinary Services (NAICS 54194) reports (2025–2026): 56,756 establishments (2025) and 57,920 (2026); industry revenue $74.5 billion (2026, +1.5%); Emergency Veterinary Services ~$49.5 billion (2024, IBISWorld scope); ~14.4% industry profit margin (2023, via Ankura). Broader establishment basis than the Census/AVMA practice universe; not comparable to APPA consumer-spend.
  3. American Pet Products Association (APPA), 2026 State of the Industry Report (released March 26, 2026): total U.S. pet-industry spending $152 billion (2024) and $158 billion (2025, +3.7%); veterinary care $41 billion (25.9% of total, +3% YoY); $165 billion projected for 2026; 71% of households (~94 million) owned a pet in 2024; 2030 forecast lowered from $250 billion to ~$192 billion.
  4. Grand View Research: U.S. veterinarians market $15.87 billion (2024), a services/professional-fee basis distinct from IBISWorld industry revenue and APPA consumer spend.
  5. Vetsource, January 2026 white paper (6,451 U.S. practices) and data presented at VMX (January 2026): veterinary visits down 3.1% (2025), 2.6% (2024), 1.4% (2023), and 3.5% (2022); wellness visits −3.8% and product-only visits −6.2% in 2025; average inter-visit interval up from ~57.6 days (2020–21) to ~85.8 days (2023–24), a 48% increase; revenue per patient ~$622 (2024, $499 services + $203 product); ~$2.7 million average revenue per practice (2025, skewed by large practices).
  6. Brakke Consulting (John Volk), VMX commentary (January 2026) and "Forecasting Supply and Demand Indicators for US Veterinarians 2024–2035" (2024): 2025 revenue up ~2.5% as visits fell ~3%; 81% of veterinarians reporting clients more cost-sensitive than 2024; existing colleges adequate to meet companion-animal demand through at least 2035, with companion-animal veterinarian numbers projected from ~80,000 (2022) to 98,000+ (2030).
  7. PetSmart Charities–Gallup State of Pet Care Study (fielded November 13, 2024–January 9, 2025; 2,498 U.S. dog/cat owners; ±2.6 points): 52% of owners skipped or declined necessary veterinary care; 71% of those cite cost. AVMA chief economist Katelyn McCullock (October 2024): the deferral trends are "here to stay for 2025."
  8. Mars Veterinary Health / Dr. Jim Lloyd, "Pet Healthcare in the U.S.: Another Look at the Veterinarian Workforce" (Animal Health Economics, August 2023): projected shortage of 14,000–24,000 companion-animal veterinarians by 2030 (an 11–18% shortfall against a need for 45,000–55,000); ~39% of veterinarians over 55 (Lloyd 2021).
  9. AAVMC, "Demand for and Supply of Veterinarians in the U.S. to 2032" (2024): only ~76% of veterinarian demand met by 2032.
  10. AVMA, 2024 Census of Veterinarians: 0.7% veterinarian unemployment (up from 0.5% in the 2023 Census) against a 3.9% U.S. rate (April 2024); workforce ~130,415 (2024); food-animal 3.4%, equine 5.9%, and mixed 9.6% of the workforce.
  11. U.S. Bureau of Labor Statistics: median veterinarian wage $125,510 (May 2024, 10% projected employment growth 2024–2034); ~134,200 veterinary technologists/technicians (May 2024); veterinary-services CPI up 7.6–7.9% annually (2023–2024), well above general CPI.
  12. NAVTA, 2024 Demographic Survey: average veterinary-technician gross income $53,759 (hourly $26.50 in 2022 to $32.89 in 2024); 56% cite low income as the top issue; "extremely satisfied" technicians fell from 25% (2022) to 8% (2024). VHMA/AVMA: technician and assistant turnover 25–40% annually.
  13. JAVMA: a 2010 study associating each additional credentialed technician per veterinarian with ~$93,311 higher veterinarian gross income; a 2025 viewpoint framing the workforce debate as one of distribution and utilization rather than absolute numbers.
  14. CDC (published January 2019; analysis of 11,000+ veterinarian death records, 1979–2015): female veterinarians up to 3.5x more likely to die by suicide than the general population; the 2014 CDC survey found 9% in serious psychological distress, 31% with depressive episodes, and 17% with suicidal ideation since graduation.
  15. Merck Animal Health–AVMA Veterinary Wellbeing Study (2023): 61% of veterinarians reporting higher exhaustion than the general population; burnout cost estimated at ~$1.93 billion annually (underlying Frontiers in Veterinary Science 2022 study, $1–2 billion, with large uncertainty).
  16. CT Acquisitions (2026): corporate/PE ownership ~8% of U.S. clinics (2011) to ~50% (2025), with independents ~51% of sites. Ad Astra Equity (2026): specialty/ER ~75% corporate. Advisor/market sources; treated as indicative.
  17. Transitions Elite (2026): goodwill commonly 70–90% of a veterinary purchase price, with hard assets a minor share. Provident/Ziegler/Terrapin commentary (2022–2025): corporate buyers routinely requiring 20–40% rollover equity and 2–5-year employment agreements to bond the selling doctor.
  18. PeerSense (May 2026): veterinary-services SBA 7(a) charge-off ~4.1% (resolved-loan basis) versus ~15.4% all-industry (a lender-analysis approximation on a resolved-loan/cohort basis, explicitly distinct from the SBA active-portfolio basis; do not mix bases). Today's Veterinary Business: a 0.92% 7(a) loan-failure rate (2008–2017 originations), $3.8+ billion in SBA loans to veterinarians 2008–2017, and net margins ~10–15% for small-animal GP and 15–25% for specialty/ER.
  19. Mars–VCA acquisition (2017): $9.1 billion at ~14–16x LTM EBITDA (Reuters/Bloomberg). Mission Pet Health (Southern Veterinary Partners + Mission Veterinary Partners, merged late 2024/rebranded 2025): ~$8.6 billion platform at ~17–18x EBITDA (~14.8x implied), December 2024; 840+ locations, 41 states, 20,000+ employees. Multiple-by-size gradient: 3.5–6x SDE solo, 7–11.5x multi-doctor GP, 11–15x+ platform.
  20. Consolidator credit and transaction developments: NVA/JAB acquired by Ethos/BC Partners (July 31, 2025); Thrive Pet Healthcare (TSG) downgraded to CCC+ by S&P (April 2025), "likely unsustainable" capital structure; Chewy Vet Care launch (2023–24) and Modern Animal acquisition announced (April 2026); FTC actions against JAB (2022): SAGE divestiture ($1.1 billion, California and Texas), Ethos divestiture ($1.65 billion, Richmond, Denver, San Francisco, and D.C.), and a nationwide 30-day prior-notice requirement for specialty/ER acquisitions within 25 miles of a JAB clinic.
  21. AVMA 2025 SotP unit economics (2024 data): average practice gross revenue ~$1.5 million; gross revenue per FTE veterinarian $554,982 (~$288/hour); companion-animal practices deriving 79.2% of revenue from veterinary services; average practice 3,845 sq ft, 3.5 exam rooms, $538 revenue per sq ft, $444,668 per exam room, 2.76 FTE veterinarians, 2.21:1 medical-staff-to-veterinarian ratio; ~13–14 companion appointment slots/day (~6 equine); owner time ~74% clinical, ~22% management; companion-animal dentistry 6.4% of revenue (AVMA 2023). Business Valuation Resources: $300,000–$600,000 revenue per FTE.
  22. Live Oak Bank practice survey: service-line mix (lab services ~15%, in-house pharmacy ~12.5%, preventive care ~12%, vaccinations ~7.5%, dentistry ~3%, balance exams/surgery/imaging), with diagnostics/lab and imaging the highest-margin in-house lines.
  23. NAPHIA, 2025 State of the Industry Report (compiled by WTW, ~99% of premium): U.S. gross written premium $4.7 billion (2024, +21.4% YoY); 6,405,541 pets insured at year-end; 3.9% market penetration (5.5% dogs, 2.0% cats) of the 163.6 million U.S. dog and cat population; California 18.3% of insured pets, followed by New York, Florida, and Texas.
  24. Real-estate cap rates: single-tenant net-leased veterinary ~6.9% average (Ben Reinberg; ~$1.4 million average price); Four Corners Property Trust closed a VCA Animal Hospital (New Jersey) at 7.1% (~8-year term, September 2025) and a BluePearl (Colorado) at 7.0%; indicative NNN ranges 5.5–6.75% (VCA) and 4.5–5.5% (Banfield, Mars-credit) per InvestmentGrade.com; Northmarq brokers report franchisee/independent closings above 7%. Advisor/brokerage sources; treated as indicative.
  25. Ackerman Group (2025–2026): 65–75% of selling owners own their real estate; corporate buyers paying 8–13x today versus 5–6x in 2016; U.S. veterinary invoice/visit growth negative three consecutive years. GF Data/Provident/Ziegler: the $1–3 million EBITDA cohort compressed ~1.5–2.5 turns from the 2020–2022 peak, coinciding with the Fed's 525 bps of 2022–23 tightening.
  26. Development and startup cost: de-novo freestanding construction $225–$400/sq ft (Animal Arts/BDA Architecture/Chapel Associates; Usiak $225–$350), leasehold improvements ~$130–$200/sq ft; ProjectionHub: GP clinic startup commonly $541,000–$901,000, with a modeled de-novo breakeven around month 25 and a Year-1 EBITDA loss (~$230,000); medical/imaging equipment often 30–50% of startup; specialty MRI $1M+ / CT $800K. Rule of thumb: ~1,000 sq ft and 2–2.5 exam rooms per veterinarian.
  27. U.S. Small Business Administration, SOP 50 10 8: 7(a) up to $5 million for practice acquisition, goodwill, equipment, build-out, and working capital (cash-flow-based); 504 for owner-occupied real estate (50% bank / 40% CDC / 10% borrower; 51% existing / 60% new-construction occupancy); business valuation and going-concern appraisal required for a change of ownership given heavy goodwill; green-card holders no longer SBA-eligible (2025 rule change).
  28. USDA Rural Development: Rural Veterinary Action Plan (August 2025); Veterinary Medicine Loan Repayment Program (VMLRP, up to $40,000/year, $120,000 over three years, plus tax offset) and Veterinary Services Grant Program (VSGP, up to $125,000); Business & Industry (B&I) guarantees for rural businesses; FY2026 cycle ~$18 million and 243 designated shortage areas across 46 states (Type I/II/III; VMLRP funding frozen for part of FY2025); the AVMA-championed Rural Veterinary Workforce Act (H.R. 2398/S. 1163); rural pet ownership ~71% (PetDesk).